Heart rate reduction: an old and novel candidate heart failure therapy.
作者信息
Ma Yonggang, Chilton Robert J, Lindsey Merry L
出版信息
Hypertension. 2012 May;59(5):908-10. doi: 10.1161/HYPERTENSIONAHA.111.186494. Epub 2012 Apr 9.
Abstract
摘要
相似文献
1
Heart rate reduction: an old and novel candidate heart failure therapy.
Hypertension. 2012 May;59(5):908-10. doi: 10.1161/HYPERTENSIONAHA.111.186494. Epub 2012 Apr 9.
2
Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
Hypertension. 2012 May;59(5):949-57. doi: 10.1161/HYPERTENSIONAHA.111.183913. Epub 2012 Apr 9.
3
Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H435-41. doi: 10.1152/ajpheart.00591.2008. Epub 2008 Dec 12.
4
Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.
Acta Radiol. 2014 Jul;55(6):676-81. doi: 10.1177/0284185113505276. Epub 2013 Sep 19.
5
Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure.
Eur J Heart Fail. 2008 Jun;10(6):550-5. doi: 10.1016/j.ejheart.2008.04.005. Epub 2008 May 16.
6
Effects of ivabradine and metoprolol on cardiac angiogenesis and endothelial dysfunction in rats with heart failure.
J Cardiovasc Pharmacol. 2009 Jan;53(1):9-17. doi: 10.1097/FJC.0b013e318193dfce.
7
The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure.
J Interv Card Electrophysiol. 2016 Sep;46(3):253-8. doi: 10.1007/s10840-016-0129-2. Epub 2016 Apr 2.
8
Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography.
Am J Cardiol. 2012 Jan 15;109(2):169-73. doi: 10.1016/j.amjcard.2011.08.025. Epub 2011 Oct 18.
9
Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
Cardiovasc Res. 2008 Jul 1;79(1):42-51. doi: 10.1093/cvr/cvn057. Epub 2008 Mar 1.
10
Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.
J Cardiovasc Pharmacol. 2012 Mar;59(3):260-7. doi: 10.1097/FJC.0b013e31823e5e01.
引用本文的文献
1
Immune Modulation in Heart Failure: the Promise of Novel Biologics.
Curr Treat Options Cardiovasc Med. 2018 Mar 15;20(3):26. doi: 10.1007/s11936-018-0617-z.
2
Heart rate reduction in coronary artery disease and heart failure.
Nat Rev Cardiol. 2016 Aug;13(8):493-501. doi: 10.1038/nrcardio.2016.84. Epub 2016 May 26.
3
Heart rate differentiates urgency and emergency in hypertensive crisis.
Clin Res Cardiol. 2013 Aug;102(8):593-8. doi: 10.1007/s00392-013-0570-5. Epub 2013 Apr 28.
4
Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.
Circ Res. 2013 Feb 15;112(4):675-88. doi: 10.1161/CIRCRESAHA.111.300502. Epub 2012 Dec 20.
本文引用的文献
1
Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
Hypertension. 2012 May;59(5):949-57. doi: 10.1161/HYPERTENSIONAHA.111.183913. Epub 2012 Apr 9.
2
Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice.
Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2081-92. doi: 10.1152/ajpheart.00706.2011. Epub 2011 Sep 16.
3
Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts.
Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H845-52. doi: 10.1152/ajpheart.01034.2010. Epub 2011 Jan 21.
4
Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis.
Cardiology. 2010;117(3):234-42. doi: 10.1159/000322905. Epub 2011 Jan 8.
5
Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration.
Mediators Inflamm. 2010;2010:751313. doi: 10.1155/2010/751313. Epub 2010 Dec 5.
6
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Lancet. 2010 Sep 11;376(9744):886-94. doi: 10.1016/S0140-6736(10)61259-7.
7
Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction.
Clin Transl Sci. 2009 Dec;2(6):422-30. doi: 10.1111/j.1752-8062.2009.00163.x.
8
Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats.
Crit Care Med. 2010 Feb;38(2):388-94. doi: 10.1097/CCM.0b013e3181c03dfa.
9
Effects of AT1- and beta-adrenergic receptor antagonists on TGF-beta1-induced fibrosis in transgenic mice.
Eur J Clin Invest. 2009 Oct;39(10):851-9. doi: 10.1111/j.1365-2362.2009.02183.x. Epub 2009 Jun 11.
10
Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Circulation. 2008 May 6;117(18):2377-87. doi: 10.1161/CIRCULATIONAHA.107.746537. Epub 2008 Apr 28.
Zotero 插件